Pharma channel feed

Fed­er­al Cir­cuit up­holds No­var­tis patent for heart drug En­tresto

4 months ago
Law

Ab­b­Vie part­ners with Sim­cere Phar­ma unit to de­vel­op myelo­ma drug

4 months ago
R&D

#JPM25 live blog day 1: How will Trump 2.0 im­pact the bio­phar­ma in­dus­try? Scott Got­tlieb, Bob Nelsen share per­spec­tives

4 months ago
Deals

J&J looks at po­ten­tial bid for In­tra-Cel­lu­lar — re­port

4 months ago
Deals

Post-Hoc: Big Phar­ma is los­ing the AI tal­ent war

4 months ago
People
AI

FDA ad­comm votes to sup­port Seik­a­gaku's her­ni­at­ed disc in­jec­tion

4 months ago
FDA+

Law­mak­ers ask Biden ad­min­is­tra­tion to tight­en rules around Chi­na clin­i­cal tri­als

4 months ago
China
Law

Pfiz­er touts blad­der can­cer re­sults as first ad­vance­ment for some pa­tients 'in decades'

4 months ago
R&D
FDA+

Lil­ly fi­nances new $500M biotech fund man­aged by a16z

4 months ago
Financing

Ab­b­Vie writes off $3.5B on Cerev­el drug af­ter Phase 2 fail­ures

4 months ago

Lil­ly ven­tures in­to pul­monary fi­bro­sis with start­up Me­di­ar

4 months ago
Startups
Deals

Bay­er says elin­zane­tant quelled hot flash­es in women un­der­go­ing can­cer treat­ment

4 months ago
R&D
FDA+

Af­ter lack­lus­ter 2024, bio­phar­ma in­dus­try prays stalled M&A will fi­nal­ly move in­to gear

4 months ago
Deals

Re­vance weighs com­pet­ing buy­out of­fer amid push from orig­i­nal bid­der

4 months ago
Deals

Astel­las stops de­vel­op­ing au­tol­o­gous cell ther­a­py us­ing tech from Xyphos buy­out

4 months ago
R&D
Cell/Gene Tx

Roche's Chugai part­ners with Swiss ADC biotech Araris

4 months ago
Startups
Deals

Aet­na takes Take­da to court over 'an­ti­com­pet­i­tive scheme' with gener­ic drugs

4 months ago
Law

Drug­mak­ers cut some list prices, shrink­ing room for re­bates in can­cer, asth­ma and di­a­betes

4 months ago
FDA+

BWX Tech­nolo­gies to buy Cana­di­an iso­tope mak­er for $525M

4 months ago
Deals
Manufacturing

J&J's new can­cer com­bo beats As­traZeneca's Tagris­so on sur­vival in lung tri­al

4 months ago
Marketing

Every FDA drug ap­proval from 2024: Few­er nods, but long-await­ed treat­ments cross the fin­ish line

4 months ago
FDA+

Flori­da car deal­er joins in­sulin pric­ing fight against Eli Lil­ly, Sanofi

4 months ago
FDA+
Law

Eli Lil­ly seeks to join law­suit over end of tirzepatide short­age

4 months ago
Law
Health Tech

No­vo pe­ti­tions FDA over Vic­toza com­pound­ing as first gener­ic wins ap­proval

4 months ago
FDA+
First page Previous page 18192021222324 Next page Last page
A service from the Financial Times